glp-1 in pregnancy GLP-1-Mediated and Neonatal Complications Mice GLP-1 during pregnancy study
Description
The minimum oxygen saturation significantly increased from 80.3 5.8% to 83.4 5.8% in the liraglutide treated group compared to unsignificant changes in the placebo-controlled group only treated with CPAP
Menopause-related estrogen decline accelerates bone loss and increases fracture risk
Therefore, the US Food and Drug Administration (FDA) prohibits these therapies for patients with an individual or family history of medullary thyroid carcinoma (MTC) or patients with multiple endocrine neoplasia syndrome type 2 (MEN2)
Fiber slows digestion while protein amplifies satiety hormones
CONCLUSIN La DM2 es una enfermedad progresiva que habitualmente requiere de 2 o ms frmacos para lograr un adecuado control
